Registry Helps Move Aortic Dissection Care Forward

Diagnosis, treatments and outcomes for acute aortic dissection have evolved. An international registry reveals trends and the power of data.

4:10 PM

Author | Haley Otman

What began with a modest hospital grant at the University of Michigan in 1996 is now the world's leading source of data on diagnosis, treatments and outcomes for a rare and dangerous cardiac condition.

On Monday, Kim Eagle, M.D., a director of U-M's Frankel Cardiovascular Center, presented data from 9,000 patients gathered over nearly 25 years by the International Registry of Acute Aortic Dissection, known as IRAD. Only 3 in 100,000 people per year experience aortic dissection, in which the layers of the aorta tear apart, and both early diagnosis and swift treatment are critical.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

A dissection often interferes with blood distribution to the rest of the body, risking function of important organs. In the more dangerous type of dissection, type A, about one-third of patients die within the first 24 hours without treatment, and 50 percent die within 48 hours, typically from aortic rupture.

Eagle presented lessons learned from the first quarter-century of IRAD during the featured clinical research session at the 2019 American College of Cardiology Scientific Session. The cardiologist and professor of internal medicine says he's proud to have grown this project into a global effort that is giving investigators, clinicians and surgeons valuable insight on the changes in aortic dissection care.

"Having such a large number of patients in our registry allows us to see what's working in our care plan and what we still need to do," Eagle says. "I think clinicians should be optimistic about the progress, including improved mortality, and they certainly should see the power of centers of excellence banding together to fight this rare condition."

Worldwide teamwork

IRAD brings together 55 active centers around the world, up from 12 when Eagle started it in 1996. Each center shares data on acute aortic dissection diagnosis, treatment, in-hospital mortality and five-year mortality.

Researchers can see trends happening across the world and track improving mortality rates.

SEE ALSO: Minimally Invasive Procedure Increases Options for Mitral Valve Repair

"Aortic dissection is a really devastating disease, and we need to keep working together to improve survival and morbidity," Eagle says. "Here at Michigan, we've had unique physicians, surgeons and imagers working in aortic dissection for many years, and as a result of that reputation we were able to create the IRAD effort. The Frankel CVC faculty's outstanding talent and reputation enable us to attract partnerships with such a large number of outstanding aortic centers worldwide."

The IRAD team also provides a hub of credible, current information for patients on the IRAD website, including a listing of aortic dissection centers of excellence.

"This is a disease that should be cared for by centers that treat a lot of them," Eagle says.

IRAD reveals changes in treatments, outcomes

The results from 9,000 patients covered overall data on the condition and specifics for both types of acute aortic dissections: type A, in the ascending aorta, and type B dissections, which occur in the descending aorta.

The data reveal nearly 90 percent of patients experiencing a type A dissection now receive surgical repair. In-hospital mortality is down to 16.3 percent, while surgical mortality is down to 13 percent, in trends mirrored by the improving outcomes at the Frankel CVC, Eagle says.

Five-year survival remains around 85 percent for both types of dissection.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

For patients experiencing a type B dissection, nearly a third now receive endovascular therapy instead of open surgery. In-hospital mortality rates for type B are now 7.4 percent.

In addition, Eagle reported the most common risk factors overall are hypertension, smoking and atherosclerosis.

The second 25 years

Eagle concluded his ACC presentation with an important reminder: There is still a long way to go.

"We still see significant delays in getting diagnoses, and clinicians must tell a lot of our patients that we don't understand the underlying cause of their aortic dissection. Many patients don't have other risk factors beyond hypertension," Eagle says.

Additionally, he says, many patients' aortas dissect at a smaller size than what's recommended for prophylactic repair.

Eagle envisions exponential progress as the second 25 years of IRAD get underway.

SEE ALSO: Growth of Cardio-Obstetrics Care Presents Challenges, Opportunity

"I believe we'll have much better acute diagnostics using biomarkers, a much more complete genetic library to identify patients who might be at risk and a switch to endovascular techniques for most patients rather than open surgeries," he says.

"It's all dependent on continued commitment from the key partners in the IRAD journey: skilled providers taking great care of our dissection patients, large numbers of centers adding to our knowledge and understanding, dedicated supporters including families, donors and industry, who allow us to keep doing the work, and, most importantly, the patients who give a voice to their disease by consenting for research."


More Articles About: Rounds Aortic Tear Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories man and woman in front of stadium with crowd at UM
Health Lab
Longtime Michigan football announcer makes call on heart health
A famous sports announcer for University of Michigan football finds himself getting heart care at Michigan Medicine and spreading the word to others to be proactive about their heart health.
woman walking on treadmill picking intensity on a chart that reads from easier to harder
Health Lab
Higher costs limit attendance for life changing cardiac rehab
Despite the success cardiac rehabilitation has shown at reducing heart-related deaths and hospital readmissions, higher out-of-pocket costs may prevent patients from participating in the program, a University of Michigan study suggests. 
prescription pad drawn
Health Lab
Reducing dose of popular blood thinners may limit risk of future bleeding
For people taking the popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.
older man with glasses standing at balcony with back to glass windows
Health Lab
Roy’s Michigan Answer: Second opinion saves patient’s heart
Michigan Medicine's team of cardiology experts offered an advanced, minimally invasive coronary intervention, which restored one patient back to good health
purple gloves close up holding piece
Health Lab
Recycled pacemakers function as well as new devices, international study suggests
Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and middle-income countries, where many patients cannot afford the treatment.
clinical team and patient standing together
Health Lab
Planting a tree, and hope, for a heart healthy future
A complex mitral valve repair by Michigan Medicine cardiac specialists helps restore health and happiness to one Michigan patient and his family.